| Fund ID | 805-4942443215 |
| Fund type | Venture Capital Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 0% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 0% |
| Fund | Type | Gross assets |
|---|---|---|
| Bios 2024 Co-Invest, LP | Venture Capital | $15.2M |
| Bios Onl Co-Invest II, LP | Venture Capital | $7.8M |
Bios Clinical Opportunity Fund, LP reports $23.7 million in gross assets, among the top 66% of private funds by size.
The stated minimum investment is $20,000.
Bios Clinical Opportunity Fund, LP is managed by Bios Capital Management, LP.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.